Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec;43(12):e202-e203.
doi: 10.2337/dci20-0049.

Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957

Sushrima Gan  1 , Adem Y Dawed  1 , Louise A Donnelly  1 , Anand T N Nair  1 , Colin N A Palmer  1 , Viswanathan Mohan  2 , Ewan R Pearson  3
Affiliations
Comment

Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957

Sushrima Gan et al. Diabetes Care. 2020 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Singh AK, Singh R, Khunti K. Comment on Gan et al. Efficacy of modern diabetes treatments DPP-4i, SGLT-2i, and GLP-1RA in white and Asian patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 2020;43:1948–1957 (Letter). Diabetes Care 2020;43:e200–e201. DOI: 10.2337/dc20-1950 - PubMed
    1. Gan S, Dawed AY, Donnelly LA, et al. . Efficacy of modern diabetes treatments DPP-4i, SGLT-2i, and GLP-1RA in white and Asian patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care 2020;43:1948–1957 - PMC - PubMed
    1. Cai X, Gao X, Yang W, et al. . No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: a meta-analysis. J Diabetes Investig 2018;9:850–861 - PMC - PubMed
    1. Singh AK, Singh R. Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Diabetes Metab Syndr 2020;14:715–722 - PubMed
    1. Buse JB, Wexler DJ, Tsapas A, et al. . 2019 Update to: management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487–493 - PMC - PubMed

MeSH terms

Substances